Paper35787271
Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes.
Huang Z and 11 others. BMC Ophthalmol, 2022. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes. Papers, record 35787271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35787271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Diabetic Retinopathy | Major topic |
| Humans | |
| Laser Coagulation | |
| Retrospective Studies | |
| Treatment Outcome | |
| Visual Acuity |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29492053 | Fundus fluorescence Angiography in diagnosing diabetic retinopathy. | Pak J Med Sci | 2017 | https://conductscience.org/library/papers/29492053 | PubMed |
| 2 | 24747681 | A comprehensive texture segmentation framework for segmentation of capillary non-perfusion regions in fundus fluorescein angiograms. | PLoS One | 2014 | https://conductscience.org/library/papers/24747681 | PubMed |
| 3 | 28365411 | Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. | Lancet Diabetes Endocrinol | 2017 | https://conductscience.org/library/papers/28365411 | PubMed |
| 4 | 30769149 | Retinal capillary perfusion: Spatial and temporal heterogeneity. | Prog Retin Eye Res | 2019 | https://conductscience.org/library/papers/30769149 | PubMed |
| 5 | 28490862 | Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review. | Clin Ophthalmol | 2017 | https://conductscience.org/library/papers/28490862 | PubMed |
| 6 | 9046048 | Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. | Histol Histopathol | 1997 | https://conductscience.org/library/papers/9046048 | PubMed |
| 7 | 31383482 | Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count. | Ophthalmology | 2019 | https://conductscience.org/library/papers/31383482 | PubMed |
| 8 | 22080911 | Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. | Retina | 2012 | https://conductscience.org/library/papers/22080911 | PubMed |
| 9 | 23649946 | Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. | Curr Diab Rep | 2013 | https://conductscience.org/library/papers/23649946 | PubMed |
| 10 | 26929922 | Detection of retinal capillary nonperfusion in fundus fluorescein angiogram of diabetic retinopathy. | Bioimpacts | 2015 | https://conductscience.org/library/papers/26929922 | PubMed |
| 11 | 6367724 | The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. | Arch Ophthalmol | 1984 | https://conductscience.org/library/papers/6367724 | PubMed |
| 12 | 30068515 | Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation. | Br J Ophthalmol | 2019 | https://conductscience.org/library/papers/30068515 | PubMed |
| 13 | 19262436 | Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy. | Retina | 2009 | https://conductscience.org/library/papers/19262436 | PubMed |
| 14 | 27779095 | Associations between diabetic retinopathy and systemic risk factors. | Hong Kong Med J | 2016 | https://conductscience.org/library/papers/27779095 | PubMed |
| 15 | 27128219 | Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy. | J Cell Biochem | 2016 | https://conductscience.org/library/papers/27128219 | PubMed |
| 16 | 21726427 | Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. | Acta Ophthalmol | 2011 | https://conductscience.org/library/papers/21726427 | PubMed |
| 17 | 28580199 | The Role of Systemic Risk Factors in Diabetic Retinopathy. | Curr Ophthalmol Rep | 2016 | https://conductscience.org/library/papers/28580199 | PubMed |
| 18 | 19651921 | Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. | Diabetes Care | 2009 | https://conductscience.org/library/papers/19651921 | PubMed |
| 19 | 14514599 | Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). | Diabetes Care | 2003 | https://conductscience.org/library/papers/14514599 | PubMed |
| 20 | 27417506 | Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. | Acta Ophthalmol | 2016 | https://conductscience.org/library/papers/27417506 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42550914 | The role of ceramides in the pathophysiology of diabetic retinopathy: Mechanisms and Implications for therapeutic strategies. | Diab Vasc Dis Res | 2026 | https://conductscience.org/library/papers/42550914 | PubMed |
| 42012258 | Macular, Peripapillary, and Midperipheral Nonperfusion in Diabetic Subjects: A Wide-Field OCTA Quantification. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42012258 | PubMed |
| 41915053 | Short-term natural history of non-perfusion areas in treatment-naive diabetic retinopathy patients using swept-source OCT angiography. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/41915053 | PubMed |
| 41772745 | Assessment of glycemic control among patients undergoing surgical treatment for advanced diabetic retinopathy in Saudi Arabia. | Int J Retina Vitreous | 2026 | https://conductscience.org/library/papers/41772745 | PubMed |
| 41587134 | MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy. | Ophthalmologica | 2026 | https://conductscience.org/library/papers/41587134 | PubMed |
| 41574824 | Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy. | J Diabetes Investig | 2026 | https://conductscience.org/library/papers/41574824 | PubMed |
| 39797135 | Predictors of Peripheral Retinal Non-Perfusion in Clinically Significant Diabetic Macular Edema. | J Clin Med | 2024 | https://conductscience.org/library/papers/39797135 | PubMed |
| 38592149 | The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592149 | PubMed |
| 38438795 | Retinal non-perfusion: recognizing and defining what is important. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/38438795 | PubMed |
| 37035306 | Peripheral and central capillary non-perfusion in diabetic retinopathy: An updated overview. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37035306 | PubMed |
| 36983406 | Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge. | J Clin Med | 2023 | https://conductscience.org/library/papers/36983406 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35787271
GET https://conductscience.org/api/papers/v1/35787271/references?page=2